Download PDF
Z Gastroenterol 2014; 52(5): 450-452
DOI: 10.1055/s-0034-1366260
Kommentiertes Referat
© Georg Thieme Verlag KG Stuttgart · New York

Der Anfang vom Ende der Interferontherapie? – Neue interferonfreie Behandlungsoptionen für die Hepatitis C

The Beginning of the End for Interferon Therapy? – Novel Interferon-free Treatment Options for Hepatitis C
H. W. Zimmermann
,
F. Tacke
Further Information

Publication History

Publication Date:
13 May 2014 (online)

Also available at
    Permissions and Reprints

MS Sulkowski, DF Gardiner, M Rodriguez-Torres, KR Reddy, T Hassanein, I Jacobson, E Lawitz, AS Lok, F Hinestrosa, PJ Thuluvath, H Schwartz, DR Nelson, GT Everson, T Eley, M Wind-Rotolo, S-P Huang, M Gao, D Hernandez, F McPhee, D Sherman, R Hindes, W Symonds, C Pasquinelli, DM Grasela for the AI444 040 Study Group.  Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection. N Engl J Med 2014; 370: 211 – 221.

V Kris, MD Kowdley, E Lawitz, F Poordad, DE Cohen, DR Nelson, S Zeuzem, GT Everson, P Kwo, GR Foster, MS Sulkowski, W Xie, T Pilot-Matias, G Liossis, L Larsen, A Khatri, T Podsadecki, B Bernstein. Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1. N Engl J Med 2014; 370: 222 – 232.